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diabetes in adult never-smokers
Ikenna C Eze1,2, Emmanuel Schaffner1,2, Elisabeth Zemp1,2, Arnold von Eckardstein3, Alexander Turk4,
Robert Bettschart5, Christian Schindler1,2 and Nicole Probst-Hensch1,2*
Abstract
Background: Active smoking has been linked to type 2 diabetes mellitus (T2DM) but only few recent studies have
shown environmental tobacco smoke (ETS) to be associated with DM in never-smokers. We assessed the association
between long term ETS exposure and DM, and explored effect modifications of this association in our sample.
Methods: We analysed 6392 participants of the Swiss study on air pollution and lung and heart diseases in adults
(SAPALDIA). We used mixed logistic regression models to assess the cross-sectional association between ETS and
DM. Selected variables were tested for effect modification and several sensitivity analyses were performed, mostly
treating participants’ study area as a random effect.
Results: The prevalence of DM and ETS in the sample was 5.5% and 47% respectively. There were 2779 never-smokers
with 4% diabetes prevalence. Exposure to ETS increased risk of DM in never-smokers by 50% [95% confidence
interval (CI): 1.00, 2.26], and we observed a positive dose–response relationship between ETS exposure level and DM
in never-smokers. Associations were strengthened (more than three-folds) by older age and chronic obstructive
pulmonary disease, and were stronger in post-menopausal, obese, hypertriglyceridaemic and physically inactive
participants. Estimates of association were robust across all sensitivity analyses (including inverse probability weighting
for participation bias and fixed-effect analysis for study area). ETS had no substantial associations in current and
ex-smokers in our study.
Conclusions: We found a positive association between ETS exposure and DM in never smokers. Additional longitudinal
studies involving biomarkers are needed to further explore underlying mechanisms and susceptibilities.
Keywords: Passive smoke, Type 2 diabetes, Cross-sectional study, Respiratory obstruction, Never-smokers
Introduction
Diabetes contributes significantly to global disability-
adjusted life years lost. Type 2 diabetes mellitus (T2DM)
comprises >90% of global diabetes and its age-adjusted
prevalence and incidence are steadily increasing [1].
Smoking has been established as a risk factor for inci-
dent T2DM [2]. There has been interest in the health
effects of environmental tobacco smoke (ETS), which con-
tains >4000 chemical compounds that partly overlap with
compounds inhaled in active smoke [3]. ETS is still com-
mon and creates substantial health costs; for instance
Switzerland spends an estimated 419 million Swiss Francs
in health costs due to ETS exposure [4]. ETS is produced
at different temperatures and in different forms [main-
stream smoke and side smoke] [3]. Multiple chemical com-
ponents of ETS occur in higher concentration in side-
stream than inhaled cigarette smoke [3]. These compounds
are generally inflammatory, causing blood vessel injuries
and endothelial dysfunction [5,6]. ETS also elevates plasma
fibrinogen concentrations (an acute phase plasma protein
and a biomarker for cardiorespiratory and metabolic dis-
eases) to a higher level than active smoke [7]. ETS was as-
sociated with reduced insulin sensitivity [8], glucose
intolerance [9] and metabolic syndrome [10]. Few studies
have linked ETS to incident [11] and prevalent DM [12] in
never-smokers, even in a dose–response manner [11] but
no study has explored differential susceptibilities in detail.
Studying never-smokers is important as the ETS effects are
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not intermixed with effects of previous or current active
smoking. Identification of modifying factors or susceptible
subgroups will help in identifying potentially causal path-
ways involved in the relationship between ETS and DM in
never-smokers.
We therefore assessed the association between chronic
ETS exposure and prevalent DM in an adult Swiss
cohort, and explored possible modifying factors in this
association in never-smokers.
Methods
Study Population
The Swiss Cohort Study on Air Pollution and Lung and
Heart Diseases in Adults (SAPALDIA) included 9651
participants aged 18–65 years at baseline (1991) [13,14].
The first follow-up examination in 2002 involved 8047
participants who underwent detailed computer- based
interviews and extensive health examinations. This
examination also included non-fasting blood sampling
into a biobank [14]. The sample for the present study
was 6392 participants aged 29–73 years, with complete
data on all relevant variables, drawn from this first
follow-up study. Ethical clearance for the SAPALDIA
study was obtained from the Review Boards of partici-
pating Cantons.
Definition of DM
Information on DM was not obtained at baseline there-
fore precluding us from studying incident diabetes. At
the first follow-up health interview, participants were
asked: “do you have diabetes?” and “was it diagnosed by
a doctor?” Participants were also asked about their medi-
cation history. Non-fasting blood samples were analysed
for random glucose level and HbA1c, in order to identify
undiagnosed cases. We classified participants as having
diabetes if they met one or more of the following cri-
teria: self-reported, physician-diagnosed diabetes; history
of taking anti-diabetic medication in the past month;
random blood glucose (RBG) >11.1 mmol/L; and HbA1c
concentration >0.065. HbA1c concentration was assessed
only in participants with RBG >6.1 mmol/L.
Assignment of individual exposures
At baseline and first follow-up health examination, partici-
pants were asked if they were active smokers, former
smokers or never smokers respectively. Long-term smok-
ing status was defined for participants based on their ac-
tive smoking status at baseline and follow-up. Participants
were defined as never-smokers if they reported to have
never smoked both at baseline and follow-up; current
smokers if they reported current smoking at follow-up (re-
gardless of smoking status at baseline) and ex-smokers if
they reported to be former smokers regardless of smoking
status at baseline. ETS exposure was defined as regular
exposure to ETS in the year before baseline and/or follow-
up. We then created 6 smoking categories from the long-
term smoking status and ETS exposure status of the
participants (never-smoker/no ETS; never-smoker/ETS;
ex-smoker/no ETS; ex-smoker/ETS; current smoker/no
ETS; current smoker/ETS). Participants were also asked if
they had been exposed to ETS at home or elsewhere (in-
cluding workplace, bars, restaurants etc.); the mean num-
ber of smokers they were exposed to, and mean number
of hours/day of these exposures at home, and elsewhere.
These allowed us assess any differences in effect of expos-
ure at home and outside home (considering smoking bans
in some public places in Switzerland), and to compare
our findings with previous studies. From these, we com-
puted the mean hours/day of ETS exposure for each
participant and categorized them into 0, >0 < 3 and ≥3
hours/day. This categorization was done because about
50% of those who reported ETS exposure reported 3
hours/day. Also this categorization has been used in
previous SAPALDIA publications [15], and ensures in-
ternal validity within the SAPALDIA study. All smoking
and ETS questions were derived from validated ques-
tionnaires and harmonized with the European Commu-
nity Respiratory Health Survey [16].
Potential Confounders
We selected potential confounders for this study based on
literature review and plausibility. Selected confounders in-
clude sex, age, body mass index (BMI; kg/m2), educational
level (≤9 years, 9–13 years, >13 years), neighbourhood
socio-economic index (obtained from a principal compo-
nent analysis involving educational level and occupation
of household heads, median rent and number of persons
living in a household [17]), vigorous physical activity
(defined as participation in activities that makes one
sweat or out of breath; <0.5, 0.5-2, >2 hours/week), con-
sumption of citrus fruits (including juice), other fruits
(including juice) and raw vegetables [including salad/
juice; (<1, 1–3, >3 days/week, respectively)], consumption
of alcohol (including beers, wines, liquors and spirits;
never, ≤once, >once/day). We considered occupational ex-
posure to vapours, gases, dusts or fumes (yes/no) and
pack-years smoked. Since ETS contributes to particulate
matter concentration [18,19], and studies have previously
shown a positive association between PM and diabetes
[20,21], we additionally considered mean ambient PM10
exposure (μg/m3) from baseline up until follow-up as a
potential confounder.
Estimates of annual home outdoor levels of particulate
matter <10 μm in diameter (PM10) were obtained for
each participant and each year between baseline and
first follow-up based on their address histories and
inter/extrapolations of validated dispersion model esti-
mates for the year 1990 and 2000 at all residential sites,
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using a spatial resolution of 200 × 200 m. Annual means
(between baseline and follow-up) were inter/extrapo-
lated using trends from monitoring stations nearest to
participants’ residences. Validation and inter/extrapola-
tion were done using data from the Swiss air pollution
monitoring network [22].
As potential effect modifiers, we considered sex,
age (≤50, >50 years], BMI (≤25; 25–29, ≥30 kg/m2),
educational level, physical activity, and the following
binary variables: hypertension (self-reported, or systolic
blood pressure ≥ 140 mmHg and/or diastolic blood
pressure ≥ 90 mmHg); chronic obstructive pulmonary
disease (COPD; forced expiratory volume in 1 second,
FEV1/forced vital capacity, FVC >0.7); high non-fasting
triglyceride (>1.52 mmol/L); low HDL-cholesterol (high
density lipoprotein ≤1.51 mmol/L) and high hs-CRP
(high sensitivity C-reactive protein; >1.0 mmol/L). In
women, menopausal status (post- vs. pre-) was also
considered. All of these variables were associated with
diabetes at first follow-up. Statistical Analyses.
We summarized the participants’ characteristics ac-
cording to smoking categories. We calculated propor-
tions for the categorical variables and mean/standard
deviation for the continuous variables.
We fitted a mixed logistic unadjusted regression model
to test interaction between smoking status and ETS ex-
posure in their association with diabetes, to justify the
classification of participants to their respective smoking
categories. We fitted another model with tobacco expos-
ure in 6 categories (generated from the combination of
active smoking and ETS status) and added the potential
confounders in an incremental manner. This enabled
observing the effect of each of the potential confounders
on the association between ETS exposure and DM
for each smoking category. Our fully-adjusted model
included participants’ age, sex, educational status, occu-
pational exposure to vapour, dusts and fumes, active
smoking status, smoked pack-years, alcohol consump-
tion, consumption of raw vegetables, citrus fruits and
other fruits, PM10 exposure and body mass index. We
did not consider co-morbidities and blood markers in
our fully-adjusted model (they may lie in the causal
pathway of the ETS-diabetes association), but we ex-
plored their effects by adding them separately to the
fully-adjusted model.
We introduced interaction terms between the smoking
category - ETS in never-smokers - and pre-selected po-
tential effect modifiers to the fully-adjusted model one
by one and noted the p-values of the interaction terms.
In other models, we estimated separate effects of this
smoking category for the several compared groups.
We performed several sensitivity analyses. We ad-
justed for missing information and potential participa-
tion bias using inverse probability weighting. We excluded
participants with any self-reported heart disease. We ex-
cluded participants who reported diabetes medication
use before baseline assessment. We restricted diabetes
definitions by only applying one of the criteria at a time
and excluded cases identified by “complementary” defini-
tions from respective analyses. We applied models ignor-
ing study area and treating study area as a fixed effect.
We created smoking categories based on only the baseline
smoking and ETS data; collected 10 years prior to
data obtained for diabetes classification at follow-up, and
performed similar incremental adjustment for potential
confounders.
To assess dose–response relationships, we limited the
analysis to never-smokers and tested the association be-
tween mean hours/day (categories) of ETS exposure and
prevalent diabetes by adding the potential confounding
variables also in an incremental manner.
All analyses were performed with STATA data analysis
software version 12 (STATA Corporation, Texas).
Results
The prevalence of ETS in the study population was
46.8% and 34% in never-smokers. We identified 315
cases of diabetes. In never-smokers, ETS exposure was
higher in females, younger participants, and participants
with lower educational level, lower neighbourhood
socio-economic index and lower physical activity, lower
HDL, higher hs-CRP and higher diabetes rates (Table 1).
Similar trends were observed for ex-smokers and current
smokers. Current smokers had longer duration of expos-
ure to ETS than never- and ex-smokers. ETS exposure
in current smokers was associated with higher triglycer-
ide levels and higher smoking pack-years (Table 1).
Additional file 1: Table A1 shows the baseline characteris-
tics of SAPALDIA cohort participants based on whether
they were included in the present analysis or not. While
most characteristics were significantly different, the pro-
portion of diabetes cases was the same in both groups.
We found higher odds of DM in ex-smokers (OR:
1.29; 95% CI: 0.87, 1.92) and current smokers (OR: 1.37;
95% CI: 0.80, 2.36) compared to never-smokers. Since
we found a significant interaction between ETS exposure
and smoking in their association with DM (p = 0.013),
we separately estimated the effect of ETS exposure in
never-smokers, ex-smokers and current smokers.
Exposure to ETS increased the odds of diabetes by
50% (95% CI: 0, 126%) in never smokers. There was a
positive association in ex-smokers and no sizable associ-
ation in current smokers (Table 2). Odds of diabetes
generally increased by >20% in all categories after adjust-
ing for age and sex and remained fairly stable until ad-
justment for BMI (Table 2). Adjusting for hypertension,
triglyceridaemia, HDL and hs-CRP levels did not sub-
stantially change the effect estimates (Additional file 1:
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Table 1 Characteristics of study population
Characteristic (%) Never smokers;
No ETS
Never smokers;
ETS
Ex-smokers;
No ETS
Ex-smokers;
ETS
Current Smokers;
No ETS
Current Smokers;
ETS
N = 6392 1834 945 1119 902 448 1144
Females 61 58 45 42 45 47
Educational level: ≤ 9 years 6 7 5 6 7 6
10-13 years 63 67 64 66 62 71
>13 years 30 26 32 28 30 24
Occupational exposure to gases/
dusts/ fumes
31 47 36 55 40 54
Mean hours/day exposed to ETS at
home: 0
100 55 100 55 100 34
<3 0 39 0 39 0 54
≥3 0 6 0 6 0 12
Mean hours/day exposed to ETS
elsewhere: 0
100 55 100 55 100 34
<3 0 34 0 33 0 51
≥3 0 11 0 13 0 16
Vigorous physical activity: <0.5 h/wk 35 42 40 40 44 45
0.5-2 hours/week 38 32 35 30 33 30
>2 hours/week 27 26 31 30 24 25
Alcohol intake: Never 11 11 6 8 7 9
≤ once/day 84 82 86 77 83 77
> once/day 4 6 8 15 10 15
Consumption of vegetables: Never 0 1 1 0 1 1
≤3 days/week 17 19 17 18 20 23
>3 days/week 83 80 82 82 79 76
Consumption of citrus fruits: Never 7 7 9 9 10 11
≤3 days/week 57 52 57 57 59 55
>3 days/week 36 41 34 34 31 34
Consumption of other fruits: Never 1 1 1 1 2 4
≤3 days/week 28 31 29 36 41 42
>3 days/week 71 68 70 63 57 54
Menopausea 64 55 63 54 62 47
Diabetes cases 3 5 6 7 5 4
Hypertension cases 35 34 44 38 35 31
COPD cases 16 16 22 20 25 25
High triglyceride (>1.52 mmol/l) 45 45 54 54 51 54
High HDL-cholesterol (>1.51 mmol/l) 51 47 46 43 41 35
High C-reactive protein (>1.0 mg/l) 47 47 49 52 56 44
Mean (SD)
Age (years) 52.6(11.9) 49.8(12.7) 56.1(9.8) 52.7(10.8) 52.9(10) 48.9(10.7)
BMI (kg/m2) 25.6(4.3) 26.2(4.7) 26.1(4.3) 26.7(4.4) 25.5(3.9) 25.3(4.5)
Area socio-economic index 64.6(9.7) 62.3(10.3) 65.3(9.8) 61.8(10.4) 64.7(9.9) 61.8(10.3)
Home outdoor PM10 (μg/m3) 21.9(7.3) 22.6(7.4) 21.9(7.3) 22.7(7.7) 23.6(7.5) 22.6(7.5)
Pack-years of smokingb 0(0) 0(0) 7.2(17.8) 13(27.5) 14.7(27.1) 20(28.4)
ETS: environmental tobacco smoke; BMI: body mass index; COPD: chronic obstructive pulmonary disease; PM10: particulate matter <10 μm in diameter. HDL: high
density lipoproteins; HDL divided at its sample mean whereas CRP and triglycerides were divided at their sample median. aN = 2958. bMedian (IQR).
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Table A2). We observed a positive dose–response rela-
tionship between level of ETS exposure and DM in
never-smokers. This was substantial only for home ETS
exposure. The respective odds of diabetes for ETS ex-
posure >0 < 3 hours/day and ≥3 hours/day at home were
1.01 (95% CI: 0.54, 1.88) and 2.62 (95% CI: 1.04, 6.62)
compared to no ETS exposure at home (Table 3).
On an ordinal scale, the risk of diabetes increased by
13% (95% CI: 0.97, 1.31) and 5% (0.96, 1.15) per hour of
ETS exposure at home and elsewhere respectively.
Since we found a substantial association between ETS
exposure and DM only in never-smokers, we limited the
effect modification analysis to this group. The associ-
ation between ETS and DM in never smokers was highly
strengthened by older age and COPD (Table 4). Associa-
tions were also strengthened (albeit less strongly) by fe-
male sex, obesity, physical inactivity, hypertension, high
serum triglyceride and low serum HDL, and post-
menopausal status in women (Table 4).
The effect estimates remained robust and positive across
most sensitivity analyses. Adjusting for participation bias,
ignoring study area and treating study area as a fixed effect
did not sizably change the odds of diabetes (Additional file
1: Table A3). Exclusion of participants with self-reported
heart disease or using restricted definitions of diabetes
based on self-reported diagnosis or medication intake sub-
stantially increased the odds of diabetes (Additional file 1:
Table A3). Exclusion of subjects who reportedly used anti-
diabetic medication at the baseline assessment and defin-
ing diabetes only using the blood markers marginally
reduced the odds of diabetes (Additional file 1: Table A3).
Defining exposure categories using only the baseline
smoking and ETS status did not sizably change the results
(Additional file 1: Table A4).
Discussion
We found a positive association between ETS exposure
and diabetes among never smokers in the SAPALDIA
cohort. This association was strengthened by age and re-
spiratory obstruction.
We also found a positive dose–response relationship
which was substantial for ETS exposure at home. We
observed some threshold effect for ETS exposure outside
the home. This points towards a non-linear association
but on further exploration, we found the likelihood ratio
test comparing the model with categorical hours of ETS
exposure with the model with ordinal hours of ETS ex-
posure to be insignificant (P-value > 0.2) for both expos-
ure settings. Thus we may not reject the hypothesis of a
linear dose–response relationship, particularly as these
Table 2 Association between ETS-exposure status and diabetes mellitus according to smoking status
ETS (yes vs. no) in never
smokers OR (95% CI)
ETS (yes vs. no) in ex-smokers
OR (95% CI)
ETS (yes vs. no) in current
smokers OR (95% CI)
Unadjusted 1.54 (1.05, 2.27) 1.02 (0.71, 1.45) 0.80 (0.48, 1.35)
Adjusted for age and sex 1.86 (1.26, 2.76) 1.26 (0.87, 1.82) 1.07 (0.63, 1.82)
+ socio-economic status 1.81 (1.22, 2.69) 1.21 (0.84, 1.75) 1.05 (0.62, 1.78)
+ lifestyle characteristicsa 1.75 (1.17, 2.60) 1.19 (0.81, 1.73] 1.06 (0.62, 1.82)
+ home outdoor PM10 1.73 (1.16, 2.57) 1.17 (0.81, 1.71) 1.06 (0.62, 1.81)
+ body mass index 1.50 (1.00, 2.26) 1.07 (0.73, 1.57) 0.93 (0.54, 1.61)
Socio-economic status includes educational attainment and area-level socio-economic position; ainclude alcohol consumption, smoking pack-years, work exposure
to dust gas and fumes, citrus fruits, other fruits and raw vegetables, and physical activity. OR: odds ratio. OR values represent % increase in diabetes prevalence
for exposure to ETS in each smoking group. CI: confidence interval. PM10: particulate matter <10 μm in diameter. Area was treated as a random effect in all
models. + indicates additional adjustment. N = 6392 at all levels of adjustment.
Table 3 Dose–response relationship between ETS exposure and DM in never-smokers
ETS exposure >0 < 3 hours/
day at homea OR (95% CI)
ETS exposure ≥3 hours/
day at homea OR (95% CI)
ETS exposure >0 < 3 hours/
day elsewhereb OR (95% CI)
ETS exposure ≥3 hours/
day elsewhereb OR (95% CI)
Unadjusted 1.06 (0.60, 1.85) 3.35 (1.46, 7.69) 1.47 (0.87,2.47) 0.98(0.35,2.72)
Adjusted for age and sex 1.41 (0.79, 2.51) 3.51 (1.48, 8.33) 1.77 (1.03,3.03) 1.55(0.54,4.44)
+ socio-economic status 1.33 (0.75, 2.38) 3.44 (1.45, 8.14) 1.69 (0.98,2.92) 1.47(0.51,4.22)
+ lifestyle characteristicsc 1.26 (0.70, 2.28) 2.83 (1.18, 6.82) 1.55 (0.89,2.69) 1.40(0.48,4.09)
+ home outdoor PM10 1.27 (0.70, 2.30) 2.81 (1.17, 6.75) 1.55 (0.89,2.70) 1.41(0.49,4.09)
+ body mass index 1.01 (0.54, 1.88) 2.62 (1.04, 6.62) 1.25 (0.70,2.24) 1.31(0.43,4.01)
aestimates are compared with no ETS exposure at home. bestimates are compared with no ETS exposure elsewhere. Socio-economic status includes educational
attainment and area-level socio-economic position; cinclude alcohol consumption, smoking pack-years, work exposure to dust gas and fumes, citrus fruits, other
fruits and raw vegetables, and physical activity. OR: odds ratio. OR values represent % increase in diabetes prevalence for exposure to ETS compared to the
reference group. CI: confidence interval. PM10: particulate matter <10 μm in diameter. Area was treated as a random effect in all models. + indicates additional
adjustment. N = 2779.
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dose–response relationships were observed using only
three categorical data points.
Major characteristics and findings of previous studies
(which reported mixed findings) on this association in
never-smokers are summarized in Additional file 1:
Table A5. While most reported a positive association be-
tween ETS exposure and DM risk [9,12,23-27], others
did not [10], despite controlling for major DM risk fac-
tors. A recent meta-analysis of six studies reported
pooled risk of diabetes to be 1.21 (95% CI: 1.07, 1.38) in
never-smokers. Few studies explored effect modification
by age [23], sex [9,23,25], race [9], BMI/obesity [25,26],
pre-diabetes status [24] and living with a regular/occa-
sional smoker [26]. No study explored modification by
physical activity, social status, menopause and co-
morbidities. Unlike our study, Ko et al. did not find any
effect modification by age [23]. Our finding of a stronger
effect in women agrees with other studies [9,23]. This
might be because women get more intense ETS expos-
ure than men (they comprise >60% of never-smokers in
our study) and/or hormonal differences impacting on
the metabolism [28,29]. We found no substantial effect
modification by BMI/obesity. Unlike Lajous et al. [26],
our results suggest effects to be stronger among the
obese. Stronger effects were reported for white race [9],
pre-diabetic subjects [24], and people living with a regu-
lar smoker [26].
We found a positive dose–response relationship only for
home ETS exposure which appeared to be stronger in
men. This may indicate that exposures at home tend to be
more intense and sustained than exposures elsewhere,
which would be consistent with the general decline in
smoking in public places in Switzerland over the past
years [30]. Lajous et al. reported a contrary finding where
they demonstrated a positive association for exposures
outside the home, which might be because they could not
assign home exposures to a large proportion of their par-
ticipants [26]. Ko et al. [23] demonstrated a positive dose–
response relationship between ETS exposure and incident
T2DM both at work and home in their population. The
differences between ETS at home and ETS elsewhere
should be interpreted with care as we observed similar
dose–response trends in exhaled carbon monoxide (CO; a
marker of recent exposure to tobacco smoke) levels in
both settings (Additional file 1: Table A6).
None of these studies explored the effect of ETS in the
three smoking groups (never-, ex- and current smokers).
Some studies either combined never- and ex-smokers
[10,12,25] or studied ETS exposure only in never smokers
[9]. One study explored effect of ETS exposure in never
and ex-smokers, but not in current smokers [24]. This
makes comparison of the various results difficult.
As suggested by Iso et al. [7], ETS elevates plasma fi-
brinogen levels. Our finding of effect modification by
Table 4 Patterns of susceptibility to ETS in association
with diabetes mellitus, in never smokers
Variable Categories ETS (yes vs. no)
in never-smokers.
OR (95% CI)
Age ≤ 50 years 0.32 (0.07, 1.60)
> 50 years 1.69 (1.10, 2.60)
Interaction 0.05
Sex Males 1.23 (0.65, 2.35)
Females 1.71 (1.01, 2.92)
Interaction p-value 0.443
BMI (kg/m2) < 25 1.15 (0.42, 3.19)
25-29 1.24 (0.68, 2.27)
≥30 1.97 (1.12, 3.46)
Interaction p-value 0.261
Hypertension No 1.23 (0.56, 2.73)
Yes 1.64 (1.01, 2.66)
Interaction p-value 0.545
COPD (FEV1/FVC <0.7) No 1.18 (0.75, 1.87)
Yes 4.55 (1.69, 12.3)
Interaction p-value 0.015
Educational level ≤ 9 years 1.38 (0.44, 4.31)
>9 years 1.52 (0.98, 2.36)
Interaction 0.254
Vigorous physical activity <0.5 hours/week 1.88 (1.09, 3.19)
≥0.5 hours/week 1.05 (0.62, 1.79)
Interaction p-value 0.160
Triglyceride level (mmol/l) ≤ 1.52 0.89 (0.38, 2.10)
> 1.52 1.85 (1.13, 3.02)
Interaction p-value 0.149
HDL level (mmol/l) ≤ 1.51 1.59 (0.96, 2.61)
> 1.51 1.34 (0.61, 2.94)
Interaction p-value 0.718
C-reactive protein (mg/l) ≤1.0 1.71 (0.83, 3.56)
>1.0 1.47 (0.89, 2.45)
Interaction p-value 0.742
Menopause No 0.56 (0.07, 4.33)
Yes 2.14 (1.13, 4.05)
Interaction p-value 0.217
OR: odds ratio, CI: confidence interval; COPD: chronic obstructive pulmonary
disease, FEV1: forced expiratory volume in 1 second, FVC: forced vital capacity.
HDL: high density lipoproteins. OR values represent % increase in prevalent
diabetes for ETS exposure in never smokers in each category. Triglyceride
and C-reactive protein were grouped by its median value while HDL was
grouped by its mean value. Area was treated as a random effect in all models.
Group-specific estimates were obtained from a single model. P-values of
interaction terms (between exposure and potential effect modifiers) were
obtained from a separate model.
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age and COPD are consistent with a fibrinogen-related
pathway, since plasma fibrinogen increases with age [31]
and is a biomarker associated with COPD risk [32].
ETS has been shown to cause adipose tissue inflamma-
tion and alter lipid profiles [33]. Holay et al. demonstrated
higher levels of serum lipids among active and passive
smokers [5], and Xie et al. showed an association between
ETS and metabolic syndrome, including its individual lipid
components [10]. We found stronger associations with
ETS among people with high triglyceride, low HDL-
cholesterol level and obesity, which also points to a path-
way involving lipids. Particulate matter concentration is
influenced by ETS and has also been shown to cause adi-
pose tissue inflammation, endothelial dysfunction and im-
paired insulin signalling in animal models [34].
Hormonal changes in menopause may enhance visceral
adiposity, high levels of adipokines and tumour necrosis
factor-alpha [35,36], which are risk factors for insulin
resistance. Our results showed a >2-fold risk of DM for
ETS exposure in post-menopausal compared to pre-
menopausal women. Henkin et al. demonstrated reduced
insulin sensitivity on ETS exposure both in never- and ex-
smokers, which was more pronounced in females [8].
This analysis draws from the large database of the
SAPALDIA study with detailed socio-demographic, life-
style and health characteristics of participants. The ETS
exposures were assigned based on detailed questions re-
garding the smoking habits of participants and the
people around them. We observed little or no inconsist-
encies in self-reported smoking status at baseline and
follow-up, for instance, none of the never-smokers at
follow-up reported smoking at baseline. Our adjustment
for socio-economic (SE) differences did not only include
individual educational attainment, but also SE status at
neighbourhood-level. Moreover, we controlled for poten-
tial confounding effects from exposure to ambient air
pollution, using home outdoor levels of PM10, and from
exposure at work, by using an indicator variable for oc-
cupational exposure to dusts, gases and fumes. Our out-
come definition was based on an algorithm attempting
to minimise misclassification. We assessed effect modifi-
cation by selected variables to help understand potential
pathways involved in the observed associations.
We used a cross-sectional design and all estimates of
ETS exposure were self-reported which poses a risk for
bias. Ideally, cotinine concentrations are measured to
objectively assess ETS exposure. Nevertheless we expect
some reliability in the self-reported ETS exposure as
they have been shown to moderately correlate with
serum cotinine measures [37,38]. Also, we observed a
positive gradient in mean expired CO levels stratified
by categories of self-reported hours of ETS exposure
(Additional file 1: Table A6). We did not have any infor-
mation on family history of diabetes and were unable to
differentiate adult type 1 diabetes (T1DM) from T2DM
in our population. We expect a small bias due to T1DM
since most of the global diabetes burden and adult dia-
betes diagnosis are due to T2DM [39]. We did not have
information on time of diagnosis for many DM cases
but about 90% of those on DM medication reported
intake after baseline examination. We explored this in
a sensitivity analysis by excluding the few cases that
reported diabetes medication intake before baseline
examination. Our results might have been affected by
participation bias since only 67% of the original cohort
participants could be included in the analyses. Therefore,
we conducted a sensitivity analysis using inverse probabil-
ity weighting. The fact that these results were very similar
to the original ones does not rule out participation bias
completely but reduces concerns to some extent.
Estimates of association remained robust across most
sensitivity analyses apart from exclusion of reported dia-
betes prior to baseline. This could mean that excluded
cases (reportedly diagnosed before baseline) may have had
a longer exposure duration compared to the other cases.
Also, they are older and we have shown association to
be stronger in older people. We cannot entirely exclude
under-diagnosis or under- or over-reporting of diabetes in
the absence of a clinical diabetes assessment in all partici-
pants. Unless this misclassification is related to ETS, we
would expect it to bias associations towards null.
Our findings in ex-smokers and current smokers are not
surprising, especially for current smokers because of their
constant exposure to their own active smoke. It would be
necessary to further explore this in ex-smokers, taking
into account the time between smoking cessation and ETS
exposure assessment. A hypothesis is that effects of ETS
increase with longer duration between smoking cessation
and ETS exposure assessment.
Conclusion
We found a positive association between ETS exposure
and DM in never smokers, which was significantly stronger
in older subjects and in subjects with COPD. High quality
longitudinal studies including various biomarkers are
needed to explore these effect modifications in more detail.
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